Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Inks Group Purchasing Deal with Novation

NEW YORK (GenomeWeb News) – Cepheid said today that it has signed a group purchasing deal with Novation for its GeneXpert System and Xpert MRSA (methicillin-resistant Staphylococcus aureus) tests.
 
Under the agreement, customers of Novation, a large group purchasing organization that serves hospital systems including VHA, University HealthSystem Consortium, and Provista, will be able to purchase the molecular diagnostics instrument and tests at undisclosed pre-negotiated prices. According to a Cepheid statement, Novation purchasing power represents 49 percent of admissions and 44 percent of staffed beds in the US.
 
The pact follows last week’s announcement of a similar arrangement between Cepheid and Premier, a group purchasing organization that has more than 1,500 hospitals in its network.
 

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.